S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Verve Therapeutics (VERV) SEC Filings & 10K Form

$6.64
-0.02 (-0.30%)
(As of 04/19/2024 ET)

Recent Verve Therapeutics SEC Filings

DateFilerForm TypeView
04/03/2024
4:00 PM
Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:13 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:32 AM
Verve Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
7:00 AM
Verve Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2024
6:45 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:13 AM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
01/16/2024
10:45 AM
SINGER JAMES R (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
12/11/2023
8:09 AM
FMR LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
12/05/2023
3:50 PM
Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/05/2023
3:30 PM
Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:30 PM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
3:54 PM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
3:47 PM
Verve Therapeutics (Filer)
Form 424B5
11/28/2023
3:25 PM
Verve Therapeutics (Filer)
Form 424B5
11/13/2023
5:34 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:00 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
5:41 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:00 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
8:02 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
5:37 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
6:33 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
6:00 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
6:49 AM
Verve Therapeutics (Filer)
Form DEFA14A
04/28/2023
6:52 AM
Verve Therapeutics (Filer)
Form ARS
04/28/2023
6:30 AM
Verve Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VERV) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners